\-\ Texto\\:\\ \ \(0\)\
\-\ pe\\:\\ left\\ hip\\ is\\ held\\ flexed\\,\\ abducted\\,\\ externally\\ rotated\\.\ \(0\)\
\-\ labs\\:\\ normal\\ crp\\,\\ esr\\,\\ wbc\\.\ \(0\)\
\-\ nsaids\\ may\\ shorten\\ the\\ duration\\ of\\ symptoms\\.\\ \ \(0\)\
\-\ patients\\ with\\ ts\\ usually\\ experience\\ marked\\ improvement\\ within\\ 24\\-48\\ hours\\.\\ two\\ thirds\\ to\\ three\\ fourths\\ of\\ patients\\ with\\ ts\\ have\\ complete\\ resolution\\ within\\ 2\\ weeks\\.\\ the\\ remainder\\ may\\ have\\ less\\-severe\\ symptoms\\ for\\ several\\ weeks\\.\ \(0\)\
\-\ the\\ recurrence\\ rate\\ is\\ 4\\-17\\%\\;\\ most\\ recurrences\\ develop\\ within\\ 6\\ months\ \(0\)\
\-\ if\\ significant\\ symptoms\\ persist\\ for\\ 7\\-10\\ days\\ after\\ the\\ initial\\ presentation\\,\\ consider\\ other\\ diagnoses\\.\\ \ \(0\)\
\-\ advise\\ that\\ all\\ patients\\ with\\ ts\\ have\\ repeat\\ radiographs\\ within\\ 6\\ months\\ to\\ exclude\\ lcp\\ disease\\.\ \(0\)\
\-\ ultrasound\\ of\\ the\\ hips\\ demonstrates\\ a\\ left\\-sided\\ hip\\ effusion\\ measuring\\ approximately\\ \\ 2\\.9\\ cm\\ \\(cc\\)\\ x\\ 0\\.8\\ cm\\ \\(trv\\)\\,\\ asymmetric\\ when\\ compared\\ to\\ the\\ right\\ hip\\.\\ the\\ joint\\ fluid\\ demonstrates\\ diffuse\\ low\\ level\\ echoes\\.\ \(0\)\
\-\ transient\\ synovitis\\ of\\ the\\ hip\ \(0\)\
\-\ 1\\.\\ \\ septic\\ arthritis\ \(0\)\
\-\ 2\\.\\ \\ transient\\ synovitis\ \(0\)\
\-\ 3\\.\\ \\ juvenile\\ ra\ \(0\)\
\-\ 4\\.\\ \\ malignancy\\ \\(leukemia\\)\ \(0\)\
\-\ 5\\.\\ \\ sickle\\ cell\\ anemia\ \(0\)\
\-\ 6\\.\\ \\ legg\\-calve\\-perthes\\ \\(lcp\\)\\ disease\ \(0\)\
\-\ 7\\.\\ \\ fracture\ \(0\)\
\-\ 8\\.\\ \\ soft\\ tissue\\ injury\ \(0\)\
\-\ 5\\ year\\ old\\ female\\ with\\ new\\ unilateral\\ left\\ hip\\ pain\\ with\\ limp\\.\\ low\\ grade\\ fever\\.\\ antecedent\\ uri\\ 5\\ weeks\\ prior\\.\\ no\\ known\\ trauma\\.\ \(0\)\
\-\ recent\\ history\\ of\\ upper\\ respiratory\\ infection\\ \\(pharyngitis\\,\\ bronchitis\\,\\ otitis\\ media\\)\\ elicited\\ in\\ approximately\\ 50\\%\\ of\\ patients\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ ts\\:\\ 0\\.3025844135691787\ \(0\)\
\-\ hip\\:\\ 0\\.2979125187737973\ \(0\)\
\-\ lcp\\:\\ 0\\.23705635548064471\ \(0\)\
\-\ patients\\:\\ 0\\.1745355121715577\ \(0\)\
\-\ synovitis\\:\\ 0\\.16873534032641485\ \(0\)\
\-\ transient\\:\\ 0\\.15258790573458422\ \(0\)\
\-\ within\\:\\ 0\\.14289397331115558\ \(0\)\
\-\ weeks\\:\\ 0\\.13945651660711986\ \(0\)\
\-\ symptoms\\:\\ 0\\.1273155487193805\ \(0\)\
\-\ fourths\\:\\ 0\\.12404139785398968\ \(0\)\
\-\ the\\:\\ 0\\.12381430476208936\ \(0\)\
\-\ shorten\\:\\ 0\\.11852817774032236\ \(0\)\
\-\ have\\:\\ 0\\.1162421140083379\ \(0\)\
\-\ advise\\:\\ 0\\.11461648581796942\ \(0\)\
\-\ abducted\\:\\ 0\\.11158234184173246\ \(0\)\
\-\ antecedent\\:\\ 0\\.10700723669572852\ \(0\)\
\-\ pharyngitis\\:\\ 0\\.10519157378194918\ \(0\)\
\-\ held\\:\\ 0\\.1021574298057122\ \(0\)\
\-\ externally\\:\\ 0\\.09967835366828184\ \(0\)\
\-\ recurrences\\:\\ 0\\.09967835366828184\ \(0\)\
\-\ trv\\:\\ 0\\.09967835366828184\ \(0\)\
\-\ approximately\\:\\ 0\\.09898270265026407\ \(0\)\
\-\ bronchitis\\:\\ 0\\.09664420969204487\ \(0\)\
\-\ uri\\:\\ 0\\.09494233216072406\ \(0\)\
\-\ flexed\\:\\ 0\\.09143655915370599\ \(0\)\
\-\ of\\:\\ 0\\.09107335111554048\ \(0\)\
\-\ months\\:\\ 0\\.0902968107276183\ \(0\)\
\-\ thirds\\:\\ 0\\.09025344163226158\ \(0\)\
\-\ echoes\\:\\ 0\\.09025344163226158\ \(0\)\
\-\ limp\\:\\ 0\\.09025344163226158\ \(0\)\
\-\ cm\\:\\ 0\\.08909153750396023\ \(0\)\
\-\ low\\:\\ 0\\.08901305390631033\ \(0\)\
\-\ otitis\\:\\ 0\\.08865191344094718\ \(0\)\
\-\ rotated\\:\\ 0\\.08815741262368801\ \(0\)\
\-\ persist\\:\\ 0\\.08815741262368801\ \(0\)\
\-\ elicited\\:\\ 0\\.08677344545543754\ \(0\)\
\-\ media\\:\\ 0\\.08634174970990866\ \(0\)\
\-\ crp\\:\\ 0\\.08297185351808052\ \(0\)\
\-\ diagnoses\\:\\ 0\\.08201164711768573\ \(0\)\
\-\ hips\\:\\ 0\\.08170607754235727\ \(0\)\
\-\ left\\:\\ 0\\.07937610895863446\ \(0\)\
\-\ may\\:\\ 0\\.07806509727662557\ \(0\)\
\-\ demonstrates\\:\\ 0\\.0779344168343323\ \(0\)\
\-\ experience\\:\\ 0\\.07713097239635333\ \(0\)\
\-\ ra\\:\\ 0\\.07670602300365707\ \(0\)\
\-\ sickle\\:\\ 0\\.07670602300365707\ \(0\)\
\-\ consider\\:\\ 0\\.07629395286729211\ \(0\)\
\-\ juvenile\\:\\ 0\\.07629395286729211\ \(0\)\
\-\ with\\:\\ 0\\.07593980618427537\ \(0\)\
\-\ nsaids\\:\\ 0\\.07589400421499728\ \(0\)\
\-\ cc\\:\\ 0\\.0751277579041679\ \(0\)\
\-\ exclude\\:\\ 0\\.07494275812718716\ \(0\)\
\-\ duration\\:\\ 0\\.07476024164376738\ \(0\)\
\-\ septic\\:\\ 0\\.07371378129125959\ \(0\)\
\-\ develop\\:\\ 0\\.07140361756022108\ \(0\)\
\-\ anemia\\:\\ 0\\.07126271190699583\ \(0\)\
\-\ esr\\:\\ 0\\.07098520689035107\ \(0\)\
\-\ unilateral\\:\\ 0\\.07098520689035107\ \(0\)\
\-\ leukemia\\:\\ 0\\.07084854972141445\ \(0\)\
\-\ asymmetric\\:\\ 0\\.06980208936890667\ \(0\)\
\-\ remainder\\:\\ 0\\.06825663248944254\ \(0\)\
\-\ repeat\\:\\ 0\\.06803372136839292\ \(0\)\
\-\ improvement\\:\\ 0\\.0677060603603331\ \(0\)\
\-\ disease\\:\\ 0\\.06511705341156421\ \(0\)\
\-\ pe\\:\\ 0\\.06412202944604001\ \(0\)\
\-\ recurrence\\:\\ 0\\.06403937099176117\ \(0\)\
\-\ arthritis\\:\\ 0\\.06308478446078103\ \(0\)\
\-\ resolution\\:\\ 0\\.06293200449551375\ \(0\)\
\-\ compared\\:\\ 0\\.06270600582163288\ \(0\)\
\-\ respiratory\\:\\ 0\\.061698339429406585\ \(0\)\
\-\ measuring\\:\\ 0\\.06000462597749958\ \(0\)\
\-\ hours\\:\\ 0\\.0591155986943952\ \(0\)\
\-\ rate\\:\\ 0\\.058775649141572\ \(0\)\
\-\ marked\\:\\ 0\\.058664195453169615\ \(0\)\
\-\ to\\:\\ 0\\.05817239103208131\ \(0\)\
\-\ malignancy\\:\\ 0\\.0580670136018479\ \(0\)\
\-\ effusion\\:\\ 0\\.05759719540815314\ \(0\)\
\-\ grade\\:\\ 0\\.05577512019816668\ \(0\)\
\-\ wbc\\:\\ 0\\.05482205495537958\ \(0\)\
\-\ complete\\:\\ 0\\.054369456401959906\ \(0\)\
\-\ 50\\:\\ 0\\.054168606755153836\ \(0\)\
\-\ labs\\:\\ 0\\.05373691100962496\ \(0\)\
\-\ new\\:\\ 0\\.05365987242476077\ \(0\)\
\-\ presentation\\:\\ 0\\.05339362359081785\ \(0\)\
\-\ fever\\:\\ 0\\.05258924924192139\ \(0\)\
\-\ recent\\:\\ 0\\.052518429947167336\ \(0\)\
\-\ three\\:\\ 0\\.052066882553259225\ \(0\)\
\-\ initial\\:\\ 0\\.05203276139644489\ \(0\)\
\-\ joint\\:\\ 0\\.05111055898045735\ \(0\)\
\-\ several\\:\\ 0\\.05088946022513586\ \(0\)\
\-\ injury\\:\\ 0\\.050579713941479316\ \(0\)\
\-\ radiographs\\:\\ 0\\.050306849791071355\ \(0\)\
\-\ known\\:\\ 0\\.050217098482665534\ \(0\)\
\-\ days\\:\\ 0\\.049101238842073576\ \(0\)\
\-\ usually\\:\\ 0\\.04882928429957679\ \(0\)\
\-\ diffuse\\:\\ 0\\.048642101565827635\ \(0\)\
\-\ ultrasound\\:\\ 0\\.04784278997085484\ \(0\)\
\-\ for\\:\\ 0\\.0470179834760739\ \(0\)\
\-\ when\\:\\ 0\\.046853021796107126\ \(0\)\
\-\ level\\:\\ 0\\.046853021796107126\ \(0\)\
\-\ infection\\:\\ 0\\.046853021796107126\ \(0\)\
\-\ all\\:\\ 0\\.04617188070311937\ \(0\)\
\-\ two\\:\\ 0\\.04606160212738373\ \(0\)\
\-\ if\\:\\ 0\\.045066493827811985\ \(0\)\
\-\ trauma\\:\\ 0\\.045046092812949357\ \(0\)\
\-\ significant\\:\\ 0\\.04478362800438581\ \(0\)\
\-\ fluid\\:\\ 0\\.04478362800438581\ \(0\)\
\-\ cell\\:\\ 0\\.04437006571176638\ \(0\)\
\-\ fracture\\:\\ 0\\.04408218042347325\ \(0\)\
\-\ prior\\:\\ 0\\.04339708095303203\ \(0\)\
\-\ is\\:\\ 0\\.04248274581626348\ \(0\)\
\-\ upper\\:\\ 0\\.041448892143799085\ \(0\)\
\-\ soft\\:\\ 0\\.04129331523081862\ \(0\)\
\-\ tissue\\:\\ 0\\.040688219892082746\ \(0\)\
\-\ most\\:\\ 0\\.040366548950213875\ \(0\)\
\-\ other\\:\\ 0\\.04028012530849436\ \(0\)\
\-\ after\\:\\ 0\\.03762746965348189\ \(0\)\
\-\ female\\:\\ 0\\.03742810976008687\ \(0\)\
\-\ that\\:\\ 0\\.03365977934196703\ \(0\)\
\-\ normal\\:\\ 0\\.03166877842340108\ \(0\)\
\-\ history\\:\\ 0\\.02963386086086523\ \(0\)\
\-\ pain\\:\\ 0\\.02775518118697579\ \(0\)\
\-\ right\\:\\ 0\\.025715608130734747\ \(0\)\
\-\ no\\:\\ 0\\.02522286436231765\ \(0\)\
\-\ year\\:\\ 0\\.023903635281799212\ \(0\)\
\-\ old\\:\\ 0\\.022955764319223516\ \(0\)\
\-\ in\\:\\ 0\\.019295355547966856\ \(0\)\
